AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30930% above fair value
$55.45+0.43 (+0.78%)
Close on Nov 18, 2026Market cap $2.82BP/E 264.0Yield –
AtriCure net income
Net income is the profit left for shareholders after every expense, interest and tax.
AtriCure's net income for the twelve months ending Jun 30, 2026 was $10.55M. For fiscal 2025 it was -$11.45M. The highest annual figure on record is $50.20M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.45M | – |
| FY2024 | Dec 31, 2024 | -$44.70M | – |
| FY2023 | Dec 31, 2023 | -$30.44M | – |
| FY2022 | Dec 31, 2022 | -$46.47M | -192.6% |
| FY2021 | Dec 31, 2021 | $50.20M | – |
| FY2020 | Dec 31, 2020 | -$48.16M | – |
| FY2019 | Dec 31, 2019 | -$35.19M | – |
| FY2018 | Dec 31, 2018 | -$21.14M | – |
| FY2017 | Dec 31, 2017 | -$26.89M | – |
| FY2016 | Dec 31, 2016 | -$33.34M | – |
| FY2015 | Dec 31, 2015 | -$27.21M | – |
| FY2014 | Dec 31, 2014 | -$16.21M | – |
| FY2013 | Dec 31, 2013 | -$11.46M | – |
| FY2012 | Dec 31, 2012 | -$7.53M | – |
| FY2011 | Dec 31, 2011 | -$5.46M | – |
| FY2010 | Dec 31, 2010 | -$3.79M | – |
| FY2009 | Dec 31, 2009 | -$16.49M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.96M | – |
| Q1 FY2026 | Mar 31, 2026 | $108.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $1.76M | – |
| Q3 FY2025 | Sep 30, 2025 | -$267.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.19M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.75M | – |
| Q4 FY2024 | Dec 31, 2024 | -$15.57M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.85M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.01M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.79M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.06M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.48M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.17M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.27M | -112.6% |
| Q2 FY2022 | Jun 30, 2022 | -$14.84M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.18M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.74M | – |
| Q3 FY2021 | Sep 30, 2021 | $97.11M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.25M | – |
| Q1 FY2021 | Mar 31, 2021 | -$16.92M | – |
| Q4 FY2020 | Dec 31, 2020 | -$18.56M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.95M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.24M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.41M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.10M | – |
| Q3 FY2019 | Sep 30, 2019 | -$9.36M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.10M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.64M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.43M | – |
| Q3 FY2018 | Sep 30, 2018 | -$7.24M | – |
| Q2 FY2018 | Jun 30, 2018 | -$338.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.13M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.58M | – |
| Q3 FY2017 | Sep 30, 2017 | -$7.25M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.88M | – |
| Q1 FY2017 | Mar 31, 2017 | -$10.18M | – |
| Q4 FY2016 | Dec 31, 2016 | -$8.63M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.78M | – |
See a number that looks wrong?